Table 1.
Vitamin | Ocular Manifestations | Workup | Treatment |
---|---|---|---|
A | Conjunctival and corneal xerosis, Bitot spots, corneal ulceration and scarring, nyctalopia | Serum vitamin A/retinol levels | 50,000–200 000 IU IM vitamin A x 1–3 doses based on age |
B1 | Wernicke’s encephalopathy (nystagmus, ophthalmoplegia, diplopia, papilledema) | Thiamine pyrophosphate levels | 200 mg IV or oral thiamine TID until symptoms resolve followed by 10 mg daily maintenance |
B2 | Blurred vision, nyctalopia | Clinical diagnosis, can check urinary excretion rates of riboflavin | 5–100 mg oral riboflavin supplementation daily |
B9 | Optic neuropathy, increased risk of age-related macular degeneration and retinoblastoma | Serum folate (also check B12) | 1–5 mg oral folic acid supplementation daily |
B12 | Optic neuropathy, increased risk of age-related macular degeneration, dry eye disease | Serum B12 (also check folate) | 1000 µg B12 IM weekly for up to 4 weeks |
C | Hemorrhage (subconjunctival, orbital), exacerbate age-related macular degeneration | Serum vitamin C levels | 1–2 g of vitamin C daily for 3 days, then 500 mg for a week, followed by a daily dose of 100 mg for 3 months |
D | Dry eye disease, exacerbate diabetic retinopathy, optic neuritis, and thyroid eye disease | Serum 25(OH)D3 levels | Infants – 400 IU daily Adults – 400–2000 IU daily |
E | Ophthalmoplegia, strabismus, nystagmus, retinopathy, exacerbate age-related macular degeneration | Serum α-tocopherol level | 2000 mg oral vitamin E supplementation |
K | Retinal hemorrhages | Prothrombin time (PT) – elevated | Infants – 1 mg IM injection Adults – 90 µg/day oral (women), 120 µg/day (men) |